These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 7870901

  • 1. Biphasic locomotor effects of the dopamine D1 agonist SKF 38393 and their attenuation in non-habituated mice.
    Tirelli E, Terry P.
    Psychopharmacology (Berl); 1993; 110(1-2):69-75. PubMed ID: 7870901
    [Abstract] [Full Text] [Related]

  • 2. Stimulating dopamine D1 receptors increases the locomotor activity of developing rats.
    Shieh GJ, Walters DE.
    Eur J Pharmacol; 1996 Sep 12; 311(2-3):103-7. PubMed ID: 8891588
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the effects of the D1 receptor antagonists SCH 23390 and SCH 39166 on suppression of feeding behavior by the D1 agonist SKF38393.
    Terry P, Katz JL.
    Psychopharmacology (Berl); 1994 Jan 12; 113(3-4):328-33. PubMed ID: 7862841
    [Abstract] [Full Text] [Related]

  • 4. SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?
    Cools AR, Lubbers L, van Oosten RV, Andringa G.
    Neuropharmacology; 2002 Feb 12; 42(2):237-45. PubMed ID: 11804620
    [Abstract] [Full Text] [Related]

  • 5. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ, Caine SB.
    J Pharmacol Exp Ther; 2005 Feb 12; 312(2):733-41. PubMed ID: 15494551
    [Abstract] [Full Text] [Related]

  • 6. Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress.
    Kamei H, Kameyama T, Nabeshima T.
    Eur J Pharmacol; 1995 Feb 06; 273(3):229-33. PubMed ID: 7737329
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice.
    Desai RI, Terry P, Katz JL.
    Pharmacol Biochem Behav; 2005 Aug 06; 81(4):843-8. PubMed ID: 16000217
    [Abstract] [Full Text] [Related]

  • 8. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D, Osborn CV.
    Eur J Pharmacol; 2005 Dec 28; 528(1-3):88-94. PubMed ID: 16324697
    [Abstract] [Full Text] [Related]

  • 9. Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice.
    Starr BS, Starr MS.
    Neuropharmacology; 1987 Jun 28; 26(6):613-9. PubMed ID: 2955244
    [Abstract] [Full Text] [Related]

  • 10. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
    Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1995 Feb 28; 117(4):403-12. PubMed ID: 7604140
    [Abstract] [Full Text] [Related]

  • 11. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat.
    Wachtel SR, Brooderson RJ, White FJ.
    Psychopharmacology (Berl); 1992 Feb 28; 109(1-2):41-8. PubMed ID: 1365670
    [Abstract] [Full Text] [Related]

  • 12. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
    Mele A, Castellano C, Felici A, Cabib S, Caccia S, Oliverio A.
    Eur J Pharmacol; 1996 Jul 11; 308(1):1-12. PubMed ID: 8836626
    [Abstract] [Full Text] [Related]

  • 13. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S, Bergman J.
    Eur J Pharmacol; 1994 Aug 01; 260(2-3):237-41. PubMed ID: 7988649
    [Abstract] [Full Text] [Related]

  • 14. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.
    Starr MS, Starr BS.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):151-8. PubMed ID: 7493603
    [Abstract] [Full Text] [Related]

  • 15. Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434.
    Abrahams BS, Rutherford JD, Mallet PE, Beninger RJ.
    Eur J Pharmacol; 1998 Feb 19; 343(2-3):111-8. PubMed ID: 9570457
    [Abstract] [Full Text] [Related]

  • 16. DAD1- and DAD2-like agonist effects on motor activity of C57 mice: differences compared to rats.
    Halberda JP, Middaugh LD, Gard BE, Jackson BP.
    Synapse; 1997 May 19; 26(1):81-92. PubMed ID: 9097408
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB, Criswell HE, Jensen KF, Simson PE, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1992 Aug 19; 262(2):855-65. PubMed ID: 1354257
    [Abstract] [Full Text] [Related]

  • 18. Effects of dopamine D1-like receptor agonists on food-maintained operant behavior in rats.
    Katz JL, Kopajtic TA, Terry P.
    Behav Pharmacol; 2006 Jun 19; 17(4):303-9. PubMed ID: 16914948
    [Abstract] [Full Text] [Related]

  • 19. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM, Fernández M, Jantos H.
    Neuropsychopharmacology; 1990 Jun 19; 3(3):153-62. PubMed ID: 2141985
    [Abstract] [Full Text] [Related]

  • 20. Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice.
    Toyoshi T, Ukai M, Kameyama T.
    Eur J Pharmacol; 1992 Mar 17; 213(1):25-30. PubMed ID: 1354161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.